1,600
Participants
Start Date
June 12, 2024
Primary Completion Date
March 31, 2028
Study Completion Date
May 31, 2028
Dexpramipexole Dihydrochloride
Oral administration of dexpramipexole tablet
Research Site 20389-004, Skopje
Research Site 20389-007, Skopje
Research Site 20359-010, Pernik
Research Site 20359-008, Montana
Research Site 20359-016, Dimitrovgrad
Research Site 20359-016, Vidin
Research Site 30027-005, Durban
Research Site 30027-014, Durban
Research Site 30027-010, Durban
Research Site 20995-001, Kutaisi
Research Site 30054-047, Mendoza
Research Site 20054-013, Santa Fe
Research Site 20082-008, Seoul
Research Site 20359-005, Rousse
Research Site 20359-009, Sliven
Research Site 20380-003, Zhytomyr
Research Site 20380-005, Zhytomyr
Research Site 20001-047, Hawthorne
Research Site 20381-002, Belgrade
Research Site 20381-005, Belgrade
Research Site 20381-007, Belgrade
Research Site 20381-003, Valjevo
Research Site 20082-003, Anyang-si
Research Site 20380-003, Vinnytsia
Research Site 20052-014, Tijuana
Research Site 30001-291, Jacksonville
Research Site 20001-066, Miami
Research Site 20001-029, Coral Gables
Research Site 20001-001, Miami
Research Site 30001-429, Plantation
Research Site 20001-311, Miami
Research Site 20001-026, Miami
Research Site 30001-082, Miami
Research Site 20001-024, Miami
Research Site 20054-024, Miami
Research Site 30001-429, Plantation
Research Site 20001-014, Greenacres City
Research Site 20001-004, Tampa
Research Site 20082-009, Daegu
Research Site 20001-063, Toledo
Research Site 20052-002, Guadalajara
Research Site 20380-001, Ternopil
Research Site 20001-036, Elwood
Research Site 20001-044, Evansville
Research Site 20001-006, Flint
Research Site 20082-006, Jeonju
Research Site 20380-002, Chernivtsi
Research Site 20001-046, St Louis
Research Site 20380-014, Ivano-Frankivsk
Research Site 20052-012, San Juan del Río
Research Site 30001-297, Pearland
Research Site 20001-376, Northridge
Research Site 20001-374, Bakersfield
Research Site 20040-002, Brasov
Research Site 20040-004, Brasov
Research Site 20001-355, Toms River
Research Site 30054-044, Buenos Aires
Research Site 20054-017, Buenos Aires
Research Site 20054-015, Buenos Aires
Research Site 20054-022, Buenos Aires
Research Site 20054-024, Buenos Aires
Research Site 20054-008, Buenos Aires
Research Site 20054-005, Córdoba
Research Site 20054-019, Mendoza
Research Site 20054-016, Mendoza
Research Site 20054-010, Mendoza
Research Site 20054-002, San Miguel de Tucumán
Research Site 20054-020, San Miguel de Tucumán
Research Site 20055-007, Blumenau
Research Site 20055-004, Porto Alegre
Research Site 20055-010, Porto Alegre
Research Site 20055-001, São Bernardo
Research Site 20055-003, São Paulo
Research Site 20055-008, São Paulo
Research Site 20055-002, Sorocaba
Research Site 20995-005, Tbilisi
Research Site 20995-006, Tbilisi
Research Site 20995-002, Tbilisi
Research Site 20995-003, Tbilisi
Research Site 20995-004, Tbilisi
Research Site 20995-009, Tbilisi
Research Site 20081-023, Tokyo
Research Site 20048-018, Bialystok
Research Site 20048-006, Giżycko
Research Site 20048-008, Krakow
Research Site 20048-027, Krakow
Research Site 20048-033, Krakow
Research Site 20048-005, Lodz
Research Site 20048-031, Ostrów Wielkopolski
Research Site 20048-010, Piaseczno
Research Site 20048-028, Poznan
Research Site 20048-016, Poznan
Research Site 30027-010, Durban
Research Site 30027-008, Durban
Research Site 30027-009, Cape Town
Research Site 20380-004, Ivano-Frankivsk
Research Site 20380-010, Kyiv
Research Site 20380-012, Kyiv
Research Site 20380-013, Kyiv
Research Site 20380-018, Kyiv
Research Site 20380-007, Kyiv
Research Site 20044-020, Manchester
Research Site 20044-026, Rochdale
Lead Sponsor
Areteia Therapeutics
INDUSTRY